New capsule aims to improve c. diff treatment by targeting the colon
Disease control
Completed
This study tested a new delayed-release metronidazole capsule designed to deliver the drug directly to the colon, where C. diff infection occurs. The goal is to improve treatment and reduce side effects compared to standard tablets. 18 healthy adults took part to compare how the …
Phase: PHASE1 • Sponsor: Gateway Pharmaceutical LLC • Aim: Disease control
Last updated May 08, 2026 12:03 UTC